Abstract

To evaluate the impact of comorbid conditions and age on mammography use. We used data from the 2011 to 2015 Medical Expenditure Panel Survey, which contained records for 40,752 women over the age of 40. Use was defined as a mammogram within the previous 1 or 2 years, analyzed separately. A logit model was employed to evaluate associations between use and comorbidities and age. Statistical significance was defined by a P < .05 by two-sided test. Of the 36,575 women in our study sample, 45.9%, 43.6%, 3.9%, and 5.7% reported a history of hypertension (HTN), hyperlipidemia (HLD), prior heart attack (MI), and prior stroke, respectively. Among women without a comorbid condition, there was 47.3% annual mammography use. HTN and HLD were associated with increased use (2.5 and 6.8 percentage points [pp], P< .01). In comparison, prior MI was associated with decreased annual use (-8.2 pp, P < .01). Prior stroke was not significantly associated with annual mammography (-1.5 pp, P= .42). Results were similar for biennial use. The age trend in use showed that the age with maximum screening use was approximately 60 years. Mammography use was higher in patients with HTN and HLD and lower in patients with prior MI and stroke, which mayreflect differences in comorbidity-related general health care use. Use increased until it peaked around age 60. An understanding ofhow mammography use naturally evolves as people age may help better target specific populations and improve overall use of preventive care.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call